Its estimated incidence is 1 out of 100 cases of t(9;22), BCR-ABL1-positive CML, meaning approximately 1 case per 1,000,000 persons per year (4, 11, 16, 17). The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.